Bicalutamide in Treating Patients With Metastatic Breast Cancer

NCT00468715 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: bicalutamide
OTHER: diagnostic laboratory biomarker analysis
OTHER: immunohistochemistry staining method

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]